Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

This study has been completed.
Information provided by:
University of California, San Francisco Identifier:
First received: August 7, 2007
Last updated: November 7, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given